Diabetes Insulin Pen Market Outlook 2022

1
Diabetes Insulin Pen Market Outlook 2022
2
Summary

• Diabetes Insulin Pen Market is anticipated to
  surpass US 5 Billion across the top 5 European
  countries of the France, Germany, Italy, Spain
  and United Kingdom by 2022.
• Long-term Growth Projection and Development
• Prefilled(Disposable) insulin pen grasps the
  dominant share in the top 5 European countries
  insulin pen market
• In 2016, there were over 7,800 Thousand users of
  insulin pen in the top 5 European countries
• Germany insulin pen market generated more than
  US 1.5 Billion in 2016
• Spain has shown its potential to become leading
  2 market with around 20 market share in 2016

3
(No Transcript)
4

• Market growth can be attributed to factors such
  as increasing number of patients with diabetes,
  high adoption rate, user-friendly design, surging
  popularity amid consumers, help avoid
  over/under-dosing of insulin, rising market
  demand for human insulin analogs, government
  support and technological advancements in the
  field of insulin pen devices.
• The research report titled Diabetes Insulin Pen
  Market Outlook 2022 Top 5 European Countries
  Opportunity and Demand Study, Market Forecast
  2017-2022 examines the market, demand,
  competitive landscape and trends of the top 5
  European markets of the insulin pen market.
• It provides an all-round study of overall number
  of patients with diabetes and insulin users.
• It offers information on users of insulin pens,
  specifically focusing on reusable and prefilled
  insulin pen users.

5

• The report concludes with the profiles of major
  players in the insulin pen market such as Novo
  Nordisk, Eli Lilly, Sanofi, Owen Mumford and
  Ypsomed. The major market players are evaluated
  on various parameters such as company overview,
  product outlook and latest development and trends
  of the insulin pen market.
• Top 5 European Countries Covered in the Report
  Have Studied from 8 Viewpoints
• Overall Diabetes Population (2011 - 2022)
• Insulin Users (2011 - 2022)
• Insulin Pen Users (2011 - 2022)
• Reusable (Cartridge) Insulin Pen Users (2011 -
  2022)
• Prefilled (Disposable) Insulin Pen Users (2011 -
  2022)
• Insulin Pen Market (2011 - 2022)
• Reusable (Cartridge) Insulin Pen Market (2011 -
  2022)
• Prefilled (Disposable) Insulin Pen Market (2011
  - 2022)

6

• Top 5 European Countries Covered in the Report
  are as follows
• United Kingdom
• France
• Italy
• Spain
• Germany
• Key Companies Covered in the Report are as
  follows
• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford
• Ypsomed

7
Related Reports

• Global Disposable Insulin Pen Market Research
  Report 2017
• Insulin Pens, Syringes, Pumps and Injectors
  Market Global Briefing 2017
• Insulin Pen Market Size, Share, Opportunity,
  Analysis, Growth Potential Demand Forecast 2017
  - 2022
• Global Disposable Insulin Pen Sales Market Report
  2021
• Global Insulin Pen Market Outlook 2016-2021

8
Full Reports
Diabetes Insulin Pen Market Outlook 2022
Contact us atBharat Book Bureau Tel 91 22
27810772 / 27810773 Email poonam_at_bharatbook.com O
ur Blog https//www.bharatbook.com/blog/ Twitter
https//twitter.com/researchbook Facebook
https//www.facebook.com/BharatBook3B LinkedIn
http//www.linkedin.com/company/bharat-book-bureau